Sarah Cannon View Homepage


Ontology type: grid:Facility  | foaf:Organization     


Organization Info

Publications in SciGraph latest 20 shown

  • 2019-12 Avelumab (anti–PD-L1) as first-line switch-maintenance or second-line therapy in patients with advanced gastric or gastroesophageal junction cancer: phase 1b results from the JAVELIN Solid Tumor trial in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2019-12 Allogeneic hematopoietic cell transplantation provides effective salvage despite refractory disease or failed prior autologous transplant in angioimmunoblastic T-cell lymphoma: a CIBMTR analysis in JOURNAL OF HEMATOLOGY & ONCOLOGY
  • 2019-12 Correction to: Safety and efficacy of nivolumab in combination with sunitinib or pazopanib in advanced or metastatic renal cell carcinoma: the CheckMate 016 study in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2019-04 Effect of niraparib on cardiac repolarization in patients with platinum-sensitive, recurrent epithelial ovarian, fallopian tube, and primary peritoneal cancer in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2019-03-20 A phase I study of gemcitabine + dasatinib (gd) or gemcitabine + dasatinib + cetuximab (GDC) in refractory solid tumors in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2019-02 Phase I study of the anti-FcRH5 antibody-drug conjugate DFRF4539A in relapsed or refractory multiple myeloma in BLOOD CANCER JOURNAL
  • 2019-02 First-in-human study of the anti-HB-EGF antibody U3-1565 in subjects with advanced solid tumors in INVESTIGATIONAL NEW DRUGS
  • 2019-01-29 Ixazomib, lenalidomide, and dexamethasone in patients with newly diagnosed multiple myeloma: long-term follow-up including ixazomib maintenance in LEUKEMIA
  • 2018-12 A phase Ib study to assess the efficacy and safety of vismodegib in combination with ruxolitinib in patients with intermediate- or high-risk myelofibrosis in JOURNAL OF HEMATOLOGY & ONCOLOGY
  • 2018-12 Safety and efficacy of nivolumab in combination with sunitinib or pazopanib in advanced or metastatic renal cell carcinoma: the CheckMate 016 study in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2018-12 Updated efficacy of avelumab in patients with previously treated metastatic Merkel cell carcinoma after ≥1 year of follow-up: JAVELIN Merkel 200, a phase 2 clinical trial in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2018-11 Clinical activity and safety of atezolizumab in patients with recurrent glioblastoma in JOURNAL OF NEURO-ONCOLOGY
  • 2018-10-05 Publisher Correction: Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma in NATURE MEDICINE
  • 2018-10 Safety, tolerability, and preliminary activity of IMGN529, a CD37-targeted antibody-drug conjugate, in patients with relapsed or refractory B-cell non-Hodgkin lymphoma: a dose-escalation, phase I study in INVESTIGATIONAL NEW DRUGS
  • 2018-09-19 A first-in-human phase 1a study of the bispecific anti-DLL4/anti-VEGF antibody navicixizumab (OMP-305B83) in patients with previously treated solid tumors in INVESTIGATIONAL NEW DRUGS
  • 2018-08 Phase 1/1b dose escalation and expansion study of BEZ235, a dual PI3K/mTOR inhibitor, in patients with advanced solid tumors including patients with advanced breast cancer in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2018-08 Ruxolitinib + capecitabine in advanced/metastatic pancreatic cancer after disease progression/intolerance to first-line therapy: JANUS 1 and 2 randomized phase III studies in INVESTIGATIONAL NEW DRUGS
  • 2018-07 Phase I/II trial of the oral regimen ixazomib, pomalidomide, and dexamethasone in relapsed/refractory multiple myeloma in LEUKEMIA
  • 2018-06 Impact of race on dose selection of molecular-targeted agents in early-phase oncology trials in BRITISH JOURNAL OF CANCER
  • 2018-06 Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma in NATURE MEDICINE
  • JSON-LD is the canonical representation for SciGraph data.

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "foaf:homepage": [
          {
            "id": "http://sarahcannon.com/"
          }
        ], 
        "grid:establishedYear": [
          {
            "@value": "2004-01-01", 
            "type": "http://www.w3.org/2001/XMLSchema#gYear"
          }
        ], 
        "grid:hasAddress": [
          {
            "id": "http://www.grid.ac/institutes/grid.419513.b/address-0"
          }
        ], 
        "grid:id": [
          {
            "@value": "grid.419513.b"
          }
        ], 
        "grid:isni": [
          {
            "@value": "0000 0004 0459 5478"
          }
        ], 
        "grid:wikipediaPage": [
          {
            "id": "https://en.wikipedia.org/wiki/Sarah_Cannon_Research_Institute"
          }
        ], 
        "id": "http://www.grid.ac/institutes/grid.419513.b", 
        "rdfs:label": "Sarah Cannon", 
        "sdDataset": "grid", 
        "skos:altLabel": [
          {
            "@value": "Sarah Cannon Research Institute"
          }
        ], 
        "skos:prefLabel": [
          {
            "@value": "Sarah Cannon"
          }
        ], 
        "type": [
          "http://www.grid.ac/ontology/Facility", 
          "http://xmlns.com/foaf/0.1/Organization"
        ], 
        "vivo:abbreviation": [
          {
            "@value": "SCRI"
          }
        ]
      }, 
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "geo-pos:lat": [
          {
            "@value": "36.141001", 
            "type": "http://www.w3.org/2001/XMLSchema#float"
          }
        ], 
        "geo-pos:long": [
          {
            "@value": "-86.819912", 
            "type": "http://www.w3.org/2001/XMLSchema#float"
          }
        ], 
        "grid:cityName": [
          {
            "@value": "Nashville"
          }
        ], 
        "grid:countryCode": [
          {
            "@value": "US"
          }
        ], 
        "grid:countryName": [
          {
            "@value": "United States"
          }
        ], 
        "grid:hasGeonamesCity": [
          {
            "id": "http://sws.geonames.org/4644585/"
          }
        ], 
        "id": "http://www.grid.ac/institutes/grid.419513.b/address-0", 
        "sdDataset": "grid", 
        "type": [
          "http://www.grid.ac/ontology/Address"
        ]
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://www.grid.ac/institutes/grid.419513.b'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://www.grid.ac/institutes/grid.419513.b'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://www.grid.ac/institutes/grid.419513.b'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://www.grid.ac/institutes/grid.419513.b'


     

    This table displays all metadata directly associated to this object as RDF triples.

    21 TRIPLES      12 PREDICATES      13 URIs      7 LITERALS

    Subject Predicate Object
    1 grid-institutes:grid.419513.b sgo:sdDataset grid
    2 vivo:abbreviation SCRI
    3 grid:establishedYear 2004-01-01
    4 grid:hasAddress grid-institutes:grid.419513.b/address-0
    5 grid:id grid.419513.b
    6 grid:isni 0000 0004 0459 5478
    7 grid:wikipediaPage https://en.wikipedia.org/wiki/Sarah_Cannon_Research_Institute
    8 rdf:type grid:Facility
    9 foaf:Organization
    10 rdfs:label Sarah Cannon
    11 skos:altLabel Sarah Cannon Research Institute
    12 skos:prefLabel Sarah Cannon
    13 foaf:homepage http://sarahcannon.com/
    14 grid-institutes:grid.419513.b/address-0 sgo:sdDataset grid
    15 grid:cityName Nashville
    16 grid:countryCode US
    17 grid:countryName United States
    18 grid:hasGeonamesCity http://sws.geonames.org/4644585/
    19 rdf:type grid:Address
    20 geo-pos:lat 36.141001
    21 geo-pos:long -86.819912
     




    Preview window. Press ESC to close (or click here)


    ...